American Journal of Cardiology
Volume 105, Issue 2 , Pages 179-185 , 15 January 2010

Outcome of Undersized Drug-Eluting Stents for Percutaneous Coronary Intervention of Saphenous Vein Graft Lesions

  • Young Joon Hong, MD

      Affiliations

    • Heart Center of Chonnam National University Hospital, Gwangju, Korea
    • ,
  • Augusto D. Pichard, MD

      Affiliations

    • Washington Hospital Center, Washington, District of Columbia
    • ,
  • Gary S. Mintz, MD

      Affiliations

    • Cardiovascular Research Foundation, New York, New York
    • ,
  • Sang Wook Kim, MD

      Affiliations

    • Chung Ang University Hospital, Seoul, Korea
    • ,
  • Sung Yun Lee, MD

      Affiliations

    • Inje University, Ilsan Paik Hospital, Seoul, Korea
    • ,
  • Seok Yeon Kim, MD

      Affiliations

    • Seoul Medical Center, Seoul, Korea
    • ,
  • Youngkeun Ahn, MD

      Affiliations

    • Heart Center of Chonnam National University Hospital, Gwangju, Korea
    • ,
  • Myung Ho Jeong, MD

      Affiliations

    • Heart Center of Chonnam National University Hospital, Gwangju, Korea
    • ,
  • Lowell F. Satler, MD

      Affiliations

    • Washington Hospital Center, Washington, District of Columbia
    • ,
  • Kenneth M. Kent, MD, PhD

      Affiliations

    • Washington Hospital Center, Washington, District of Columbia
    • ,
  • William O. Suddath, MD

      Affiliations

    • Washington Hospital Center, Washington, District of Columbia
    • ,
  • Neil J. Weissman, MD

      Affiliations

    • Washington Hospital Center, Washington, District of Columbia
    • ,
  • Jung Chaee Kang, MD

      Affiliations

    • Heart Center of Chonnam National University Hospital, Gwangju, Korea
    • ,
  • Ron Waksman, MD

      Affiliations

    • Seoul Medical Center, Seoul, Korea
    • Corresponding Author InformationCorresponding author: Tel: (202) 877-2812; fax: (202) 877-2715

Received 19 June 2009 ,Revised 4 September 2009 ,Accepted 4 September 2009.

References 

  1. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993;89:1539–1549
  2. Trono R, Sutton C, Hollman J, Suit P, Ratliff NB. Multiple myocardial infarctions associated with atheromatous emboli after PTCA of saphenous vein grafts. Cleve Clin J Med. 1989;56:581–584
  3. Waller BF, Rothbaum DA, Gorfinkel HJ, Ulbright TM, Linnemeier TJ, Berger SM. Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein grafts. J Am Coll Cardiol. 1984;4:784–792
  4. Kaplan BM, Benzuly KH, Kinn JW, Bowers TR, Tilli FV, Grines CL, et al. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Catheter Cardiovasc Diagn. 1996;39:113–118
  5. Baim DS, Carrozza JJ. Understanding the “no-reflow” problem. Catheter Cardiovasc Diagn. 1996;1:7–8
  6. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of “no-reflow” after percutaneous coronary interventions. Circulation. 1994;89:2514–2518
  7. Abbo KM, Dooris M, Glazier S, O'Neill WW, Byrd D, Grines CL, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol. 1995;75:778–782
  8. Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J. 1995;130:239–243
  9. Lefkovits J, Holmes DR, Califf RM, Safian RD, Pieper K, Keeler G, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II Trial. Circulation. 1995;92:734–740
  10. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999;100:2400–2405
  11. de Feyter P, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993;21:1539–1549
  12. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky A, Kent KM, et al. Are we making progress with percutaneous saphenous vein graft treatment? (A comparison of 1990 to 1994 and 1995 to 1998 results). J Am Coll Cardiol. 2001;38:150–154
  13. Dooris M, Hoffmann M, Glazier S, Juran N, Reddy V, Grines CL, et al. Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. J Am Coll Cardiol. 1995;25:1700–1705
  14. Verbin CS, White RA, Donayre CE, Kopchok GE. The ideal guidance imaging system for endovascular interventions. J Cardiovasc Surg. 1996;37:5–9
  15. Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schomig A. Vessel size and long-term outcome after coronary stent placement. Circulation. 1998;98:1875–1880
  16. Iakovou I, Dangas G, Mintz GS, Mehran R, Kobayashi Y, Aymong ED, et al. Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. Am J Cardiol. 2004;93:963–968
  17. Gronenschild E, Janssen J, Tijdens F. CAAS II: a second generation system for off-line and on-line quantitative coronary angiography. Catheter Cardiovasc Diagn. 1994;33:61–75
  18. Thrombolysis in Myocardial ischemia (TIMI) IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation. 1994;89:1545–1556
  19. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478–1492
  20. Hong MK, Mintz GS, Hong MK, Abizaid AS, Pichard AD, Satler LF, et al. Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts. Am J Cardiol. 1999;84:992–998
  21. Walts AE, Fishbein MC, Sustaita H, Matloff JM. Ruptured atheromatous plaques in saphenous vein coronary bypass grafts: a mechanism of acute, thrombotic, late graft occlusion. Circulation. 1982;65:197–201
  22. Mautner SL, Mautner GC, Hunsberger SA, Roberts WC. Comparison of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary artery in the same men. Am J Cardiol. 1992;70:1380–1387
  23. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3,958 patients. Circulation. 2008;117:790–797
  24. Ellis SG, Lincoff AM, Miller D, Tcheng JE, Kleiman NS, Kereiakes D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology: evaluation of 7E3 for the prevention of ischemic complications. Evaluation of PTCA to improve long-term outcome with abciximab GPIIb/IIIa receptor blockade. J Am Coll Cardiol. 1998;32:1619–1623
  25. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation. 2002;105:1285–1290
  26. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation. 2003;108:548–553
  27. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007;50:1442–1449
  28. Kim SW, Mintz GS, Ohlmann P, Hassani SE, Fernandez S, Lu L, et al. Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol. 2006;98:1206–1211

PII: S0002-9149(09)02317-0

doi: 10.1016/j.amjcard.2009.09.006

American Journal of Cardiology
Volume 105, Issue 2 , Pages 179-185 , 15 January 2010

Article Tools

* Image Usage & Resolution